188 related articles for article (PubMed ID: 33009760)
1. Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19.
Dzhafer N; Papathanasiou JV
Folia Med (Plovdiv); 2020 Sep; 62(3):592-596. PubMed ID: 33009760
[TBL] [Abstract][Full Text] [Related]
2. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Thalha AMM; Lee YY; Besari A; Omar SFS
J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
[No Abstract] [Full Text] [Related]
3. Compassionate Use of Remdesivir for Patients with Severe Covid-19.
Grein J; Ohmagari N; Shin D; Diaz G; Asperges E; Castagna A; Feldt T; Green G; Green ML; Lescure FX; Nicastri E; Oda R; Yo K; Quiros-Roldan E; Studemeister A; Redinski J; Ahmed S; Bernett J; Chelliah D; Chen D; Chihara S; Cohen SH; Cunningham J; D'Arminio Monforte A; Ismail S; Kato H; Lapadula G; L'Her E; Maeno T; Majumder S; Massari M; Mora-Rillo M; Mutoh Y; Nguyen D; Verweij E; Zoufaly A; Osinusi AO; DeZure A; Zhao Y; Zhong L; Chokkalingam A; Elboudwarej E; Telep L; Timbs L; Henne I; Sellers S; Cao H; Tan SK; Winterbourne L; Desai P; Mera R; Gaggar A; Myers RP; Brainard DM; Childs R; Flanigan T
N Engl J Med; 2020 Jun; 382(24):2327-2336. PubMed ID: 32275812
[TBL] [Abstract][Full Text] [Related]
4. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M
Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959
[TBL] [Abstract][Full Text] [Related]
5. Compassionate Use of Remdesivir in Covid-19.
Wu J; Wu B; Lai T
N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412708
[No Abstract] [Full Text] [Related]
6. Compassionate Use of Remdesivir in Covid-19.
Hoffmann C
N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412707
[No Abstract] [Full Text] [Related]
7. Compassionate Use of Remdesivir in Covid-19.
Fätkenheuer G; Lundgren J
N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412706
[No Abstract] [Full Text] [Related]
8. Compassionate Use of Remdesivir in Covid-19.
Bonovas S; Piovani D
N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412705
[No Abstract] [Full Text] [Related]
9. Compassionate Use of Remdesivir in Covid-19. Reply.
Grein J; Myers RP; Brainard D
N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412709
[No Abstract] [Full Text] [Related]
10. Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems.
Saint-Raymond A; Sato J; Kishioka Y; Teixeira T; Hasslboeck C; Kweder SL
Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1095-1101. PubMed ID: 32909843
[TBL] [Abstract][Full Text] [Related]
11. Rapid review for the anti-coronavirus effect of remdesivir.
Li Z; Wang X; Cao D; Sun R; Li C; Li G
Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
[TBL] [Abstract][Full Text] [Related]
12. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
[No Abstract] [Full Text] [Related]
13. Missed Opportunities on Emergency Remdesivir Use.
Sarpatwari A; Kaltenboeck A; Kesselheim AS
JAMA; 2020 Jul; 324(4):331-332. PubMed ID: 32579163
[No Abstract] [Full Text] [Related]
14. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
Chua KP; Conti RM
JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187
[No Abstract] [Full Text] [Related]
15. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
16. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.
Singh AK; Singh A; Singh R; Misra A
Diabetes Metab Syndr; 2020; 14(4):641-648. PubMed ID: 32428865
[TBL] [Abstract][Full Text] [Related]
17. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
Ison MG; Wolfe C; Boucher HW
JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
[No Abstract] [Full Text] [Related]
18. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
Montastruc F; Thuriot S; Durrieu G
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
[TBL] [Abstract][Full Text] [Related]
19. Antiviral treatment for COVID-19: the evidence supporting remdesivir.
Richardson C; Bhagani S; Pollara G
Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273
[TBL] [Abstract][Full Text] [Related]
20. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
